Literature DB >> 24594196

Familial Alzheimer's disease sustained by presenilin 2 mutations: systematic review of literature and genotype-phenotype correlation.

Marco Canevelli1, Paola Piscopo2, Giuseppina Talarico3, Nicola Vanacore4, Alessandro Blasimme5, Alessio Crestini2, Giuseppe Tosto3, Fernanda Troili3, Gian Luigi Lenzi3, Annamaria Confaloni2, Giuseppe Bruno3.   

Abstract

Familial Alzheimer's disease (FAD), despite representing a rare condition, is attracting a growing interest in the scientific community. Improved phenotyping of FAD cases may have a relevant impact both in clinical and research contexts. We performed a systematic review of studies describing the phenotypic features of FAD cases sustained by PSEN2 mutations, the less common cause of monogenic AD. Special attention was given to the clinical manifestations as well as to the main findings coming from the most commonly and widely adopted diagnostic procedures. Basing on the collected data, we also attempted to conduct a genotype-phenotype correlation analysis. Overall, the mutations involving the PSEN2 gene represent an extremely rare cause of FAD, having been reported to date in less than 200 cases. They are mainly associated, despite some peculiar and heterogeneous features, to a typical AD phenotype. Nevertheless, the frequent occurrence of psychotic symptoms may represent a potential distinctive element. The scarcity of available phenotypic descriptions strongly limits the implementation of genotype-phenotype correlations.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Familial Alzheimer's disease; Genetics of dementia; Genotype–phenotype correlation; Phenotyping; Presenilin 2

Mesh:

Substances:

Year:  2014        PMID: 24594196     DOI: 10.1016/j.neubiorev.2014.02.010

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  12 in total

Review 1.  Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.

Authors:  Yunhua Peng; Peipei Gao; Le Shi; Lei Chen; Jiankang Liu; Jiangang Long
Journal:  Antioxid Redox Signal       Date:  2020-03-16       Impact factor: 8.401

Review 2.  Dantrolene, a treatment for Alzheimer disease?

Authors:  Li Liang; Huafeng Wei
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

Review 3.  Recent Progress in the Pharmacotherapy of Alzheimer's Disease.

Authors:  Rita Khoury; Kush Patel; Jake Gold; Stephanie Hinds; George T Grossberg
Journal:  Drugs Aging       Date:  2017-11       Impact factor: 3.923

4.  Restricted Location of PSEN2/γ-Secretase Determines Substrate Specificity and Generates an Intracellular Aβ Pool.

Authors:  Ragna Sannerud; Cary Esselens; Paulina Ejsmont; Rafael Mattera; Leila Rochin; Arun Kumar Tharkeshwar; Greet De Baets; Veerle De Wever; Roger Habets; Veerle Baert; Wendy Vermeire; Christine Michiels; Arjan J Groot; Rosanne Wouters; Katleen Dillen; Katlijn Vints; Pieter Baatsen; Sebastian Munck; Rita Derua; Etienne Waelkens; Guriqbal S Basi; Mark Mercken; Marc Vooijs; Mathieu Bollen; Joost Schymkowitz; Frederic Rousseau; Juan S Bonifacino; Guillaume Van Niel; Bart De Strooper; Wim Annaert
Journal:  Cell       Date:  2016-06-09       Impact factor: 41.582

5.  Loss of Spatial Memory, Learning, and Motor Function During Normal Aging Is Accompanied by Changes in Brain Presenilin 1 and 2 Expression Levels.

Authors:  Simon Kaja; Nathalie Sumien; Vidhi V Shah; Imran Puthawala; Alexandra N Maynard; Nitasha Khullar; Andrew J Payne; Michael J Forster; Peter Koulen
Journal:  Mol Neurobiol       Date:  2014-09-10       Impact factor: 5.590

Review 6.  Genetic testing in dementia - utility and clinical strategies.

Authors:  Carolin A M Koriath; Joanna Kenny; Natalie S Ryan; Jonathan D Rohrer; Jonathan M Schott; Henry Houlden; Nick C Fox; Sarah J Tabrizi; Simon Mead
Journal:  Nat Rev Neurol       Date:  2020-11-09       Impact factor: 42.937

7.  PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer's Disease: Data from PUMCH Dementia Cohort.

Authors:  Liling Dong; Caiyan Liu; Longze Sha; Chenhui Mao; Jie Li; Xinying Huang; Jie Wang; Shanshan Chu; Bin Peng; Liying Cui; Qi Xu; Jing Gao
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

8.  PSEN1 L226F mutation in a patient with early-onset Alzheimer's disease in Korea.

Authors:  Eva Bagyinszky; Sun Ah Park; Hyung Jun Kim; Seong Hye Choi; Seong Soo A An; Sang Yun Kim
Journal:  Clin Interv Aging       Date:  2016-10-12       Impact factor: 4.458

9.  Disease duration in autosomal dominant familial Alzheimer disease: A survival analysis.

Authors:  Ivanna M Pavisic; Jennifer M Nicholas; Antoinette O'Connor; Helen Rice; Kirsty Lu; Nick C Fox; Natalie S Ryan
Journal:  Neurol Genet       Date:  2020-08-18

10.  Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population.

Authors:  Ayako Suzuki; Nobuto Shibata; Koji Kasanuki; Tomoyuki Nagata; Shunichiro Shinagawa; Nobuyuki Kobayashi; Tohru Ohnuma; Yoshihide Takeshita; Eri Kawai; Toshiki Takayama; Kenya Nishioka; Yumiko Motoi; Nobutaka Hattori; Kazuhiko Nakayama; Hisashi Yamada; Heii Arai
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.